Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ark Genomic Revolution ETF (ARKG)

Ark Genomic Revolution ETF (ARKG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 7,548,621,600
  • Shares Outstanding, K 96,505
  • 60-Month Beta 1.57
Trade ARKG with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.79 (1.01%)
  • Most Recent Dividend 0.790 on 12/29/20
  • Management Fee 0.75%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 40.60%
  • Historical Volatility 29.72%
  • IV Percentile 47%
  • IV Rank 27.61%
  • IV High 68.15% on 03/05/21
  • IV Low 30.09% on 08/25/21
  • Put/Call Vol Ratio 2.55
  • Today's Volume 42,092
  • Volume Avg (30-Day) 9,163
  • Put/Call OI Ratio 1.09
  • Today's Open Interest 92,654
  • Open Int (30-Day) 98,522

Price Performance

See More
Period Period Low Period High Performance
1-Month
74.96 +0.37%
on 09/28/21
87.98 -14.48%
on 09/03/21
-9.67 (-11.39%)
since 08/27/21
3-Month
74.96 +0.37%
on 09/28/21
94.14 -20.08%
on 06/30/21
-17.77 (-19.11%)
since 06/28/21
52-Week
62.91 +19.60%
on 09/29/20
115.15 -34.66%
on 02/10/21
+12.09 (+19.14%)
since 09/28/20

Most Recent Stories

More News
How Are Genomics ETFs Responding to Q2 Earnings?

Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.

BEAM : 91.10 (-3.94%)
EDIT : 52.45 (-9.32%)
PBE : 74.55 (-2.50%)
NTLA : 139.41 (-5.54%)
CRSP : 112.15 (-4.36%)
ARKG : 75.25 (-3.83%)
GNOM : 22.29 (-4.01%)
IDNA : 51.02 (-3.54%)
Tech Bubble 2.0 + Inflation Tsunami: How to Play Them Now

Morgan Stanley warns investors 15% correction coming as market overvalued like dot-com days.

AMD : 101.52 (-6.14%)
NVDA : 206.99 (-4.44%)
TSLA : 777.56 (-1.74%)
NVTA : 28.51 (-5.22%)
ARKG : 75.25 (-3.83%)
A Comprehensive Guide to Genomic ETFs

Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.

BEAM : 91.10 (-3.94%)
EDIT : 52.45 (-9.32%)
PBE : 74.55 (-2.50%)
NTLA : 139.41 (-5.54%)
CRSP : 112.15 (-4.36%)
ARKG : 75.25 (-3.83%)
GNOM : 22.29 (-4.01%)
IDNA : 51.02 (-3.54%)
Genomics ETFs Surge on a Major Breakthrough in CRISPR Study

The genomic-editing space has come under the spotlight with the release of encouraging data from a study assessing an in vivo CRISPR-based gene editing therapy candidate, NTLA-2001.

REGN : 605.00 (-2.27%)
BEAM : 91.10 (-3.94%)
EDIT : 52.45 (-9.32%)
NTLA : 139.41 (-5.54%)
CRSP : 112.15 (-4.36%)
ARKG : 75.25 (-3.83%)
GNOM : 22.29 (-4.01%)
IDNA : 51.02 (-3.54%)
Top-Performing Biotech ETFs of Last Week

Investors may want to tap the bullishness in the sector with the best biotech ETFs of last week.

BIIB : 284.71 (-0.67%)
FBT : 166.34 (-2.54%)
SBIO : 46.29 (-2.76%)
BTEC : 54.95 (-2.80%)
ARKG : 75.25 (-3.83%)
GNOM : 22.29 (-4.01%)
ORPH : 4.21 (-4.75%)
CLOV : 7.86 (-2.96%)
Ride the Renewed Meme Stock Wave With This New ETF

Meme stocks are those that grabbed immense investor interest due to hype on social media and online forums like Reddit, WallStreetBets and Robinhood, rather than the company fundamentals, resulting in...

UNH : 398.62 (-1.64%)
CSCO : 55.52 (-1.25%)
GME : 178.60 (-5.74%)
AMC : 36.99 (-5.88%)
ARKQ : 79.74 (-2.83%)
ARKW : 140.35 (-4.05%)
ARKK : 112.14 (-4.18%)
BB : 9.79 (-3.45%)
ARKG : 75.25 (-3.83%)
KDP : 34.04 (+0.09%)
ARKF : 49.62 (-4.15%)
FOMO : 25.01 (-2.30%)
Likely Capital Gain Tax Hike a Buying Point for These ETFs?

President Joe Biden wants to raise capital gains tax to 39.6% from the current rate of 20% for those earning $1 million or more. Since the group is just 0.3% of total population, don't expect a severe...

PTF : 150.89 (-4.61%)
XRT : 94.76 (-1.93%)
PSI : 130.49 (-3.99%)
PBW : 77.64 (-3.50%)
ARKW : 140.35 (-4.05%)
IBUY : 111.77 (-3.04%)
LIT : 80.36 (-3.25%)
IPO : 64.71 (-4.44%)
ARKG : 75.25 (-3.83%)
NERD : 25.59 (-2.99%)
Thematic Investing on the Rise: ARK ETFs Leading the Pack

Thematic ETFs saw net inflows of $42.6 billion in the first two months of this year, more than three times the $13.3 billion garnered in the same period last year.

ARKQ : 79.74 (-2.83%)
ARKW : 140.35 (-4.05%)
ARKK : 112.14 (-4.18%)
ARKG : 75.25 (-3.83%)
ARKF : 49.62 (-4.15%)
Bear of the Day: CRISPR Therapeutics (CRSP)

Bear of the Day: CRISPR Therapeutics (CRSP)

NTLA : 139.41 (-5.54%)
EDIT : 52.45 (-9.32%)
CRSP : 112.15 (-4.36%)
ARKK : 112.14 (-4.18%)
ARKG : 75.25 (-3.83%)
Ark Invest ETFs Power Active Investing Growth

Active ETFs pulled in a record of more than $55 billion capital last year and $17.5 billion so far this year, bringing their AUM to $200 billion.

ARKQ : 79.74 (-2.83%)
ARKW : 140.35 (-4.05%)
ARKK : 112.14 (-4.18%)
ARKG : 75.25 (-3.83%)
ARKF : 49.62 (-4.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Fund Summary

The ARK Genomic Revolution ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials,...

See More

Key Turning Points

3rd Resistance Point 81.06
2nd Resistance Point 79.86
1st Resistance Point 79.05
Last Price 75.25
1st Support Level 77.04
2nd Support Level 75.84
3rd Support Level 75.03

See More

52-Week High 115.15
Fibonacci 61.8% 95.19
Fibonacci 50% 89.03
Fibonacci 38.2% 82.87
Last Price 75.25
52-Week Low 62.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar